Related Experiment Video

Updated: Aug 14, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Aspergillus-related lung disease

Alia Al-Alawi1, C Frank Ryan, Julia D Flint

  • 1Department of Medicine, Amiri Hospital, Safat, Kuwait.

Canadian Respiratory Journal
|November 25, 2005
PubMed

Insights

Aspergillus, a common fungus, causes diverse lung diseases from mild to life-threatening. Early diagnosis and treatment are crucial for managing invasive aspergillosis and related conditions.

Area of Science:

  • Medical Mycology
  • Pulmonology
  • Infectious Diseases

Background:

  • Aspergillus is a ubiquitous dimorphic fungus.
  • It causes a spectrum of human diseases, varying in severity based on host immunity.
  • Susceptibility is increased in individuals with compromised defenses, lung disease, or allergies.

Purpose of the Study:

  • To review the clinical, radiographic, and pathological features of aspergillus-related lung diseases.
  • To emphasize the importance of recognizing diverse presentations for timely diagnosis and treatment.
  • To highlight the spectrum of diseases caused by Aspergillus.

Main Methods:

  • Review of clinical presentations.
  • Analysis of radiographic findings.
  • Examination of pathological aspects.

Main Results:

  • Three main patterns of aspergillus-related lung disease are identified: saprophytic infestation, allergic disease, and invasive disease.
  • Saprophytic forms include airway and tissue colonization.
  • Allergic forms encompass conditions like allergic bronchopulmonary aspergillosis and asthma.
  • Invasive forms range from acute bronchopneumonia to chronic necrotizing aspergillosis and invasive pleural disease.

Conclusions:

  • A comprehensive understanding of Aspergillus-related lung diseases is essential.
  • High index of suspicion aids in diagnosing potentially lethal manifestations.
  • Prompt diagnosis and treatment improve outcomes for invasive aspergillosis and other severe forms.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: